95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.48%
Negative revenue growth while OR stands at 9.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.48%
Negative gross profit growth while OR is at 10.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
219.35%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
219.35%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
311.06%
Net income growth above 1.5x OR's 26.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
975.86%
EPS growth above 1.5x OR's 21.43%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
975.86%
Diluted EPS growth above 1.5x OR's 21.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
835.87%
OCF growth above 1.5x OR's 11.49%. David Dodd would confirm a clear edge in underlying cash generation.
835.87%
Positive FCF growth while OR is negative. John Neff would see a strong competitive edge in net cash generation.
7.47%
10Y revenue/share CAGR under 50% of OR's 191.83%. Michael Burry would suspect a lasting competitive disadvantage.
7.47%
5Y revenue/share CAGR under 50% of OR's 29.95%. Michael Burry would suspect a significant competitive gap or product weakness.
7.47%
Positive 3Y CAGR while OR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.39%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-24.39%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-24.39%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.57%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
-6.58%
Inventory is declining while OR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.06%
Similar asset growth to OR's 3.85%. Walter Schloss finds parallel expansions or investment rates.
2.07%
Under 50% of OR's 5.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-148.44%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.